JP Morgan Chase’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $933 | Hold |
216
| – | – | ﹤0.01% | 7130 |
|
|
2025
Q4 | $3.91K | Hold |
216
| – | – | ﹤0.01% | 6845 |
|
|
2025
Q3 | $3.1K | Hold |
216
| – | – | ﹤0.01% | 6845 |
|
|
2025
Q2 | $1.67K | Hold |
216
| – | – | ﹤0.01% | 6563 |
|
|
2025
Q1 | $1.28K | Hold |
216
| – | – | ﹤0.01% | 6598 |
|
|
2024
Q4 | $2.88K | Sell |
216
-1,154
| -84% | -$12.2K | ﹤0.01% | 6596 |
|
|
2024
Q3 | $11.1K | Sell |
1,370
-290
| -17% | -$2.48K | ﹤0.01% | 6349 |
|
|
2024
Q2 | $14.1K | Sell |
1,660
-52,389
| -97% | -$788K | ﹤0.01% | 6202 |
|
|
2024
Q1 | $938K | Sell |
54,049
-33,473
| -38% | -$594K | ﹤0.01% | 4393 |
|
|
2023
Q4 | $1.12M | Sell |
87,522
-259,182
| -75% | -$6.04M | ﹤0.01% | 4249 |
|
|
2023
Q3 | $12.8M | Buy |
346,704
+37,894
| +12% | +$1.69M | ﹤0.01% | 2037 |
|
|
2023
Q2 | $12.4M | Buy |
308,810
+2,579
| +0.8% | +$146K | ﹤0.01% | 2102 |
|
|
2023
Q1 | $22.2M | Buy |
306,231
+6,254
| +2% | +$607K | ﹤0.01% | 1589 |
|
|
2022
Q4 | $24.6M | Sell |
299,977
-31,359
| -9% | -$3.27M | ﹤0.01% | 1508 |
|
|
2022
Q3 | $31.3M | Sell |
331,336
-23,114
| -7% | -$2.6M | ﹤0.01% | 1295 |
|
|
2022
Q2 | $69M | Buy |
354,450
+26,854
| +8% | +$4.38M | 0.01% | 900 |
|
|
2022
Q1 | $76.1M | Buy |
327,596
+30,911
| +10% | +$9.84M | 0.01% | 963 |
|
|
2021
Q4 | $117M | Sell |
296,685
-23,948
| -7% | -$10.1M | 0.01% | 816 |
|
|
2021
Q3 | $143M | Buy |
320,633
+20,051
| +7% | +$7.18M | 0.02% | 696 |
|
|
2021
Q2 | $117M | Buy |
300,582
+32,247
| +12% | +$11.5M | 0.01% | 823 |
|
|
2021
Q1 | $96.3M | Buy |
268,335
+20,024
| +8% | +$8.85M | 0.01% | 857 |
|
|
2020
Q4 | $122M | Buy |
248,311
+25,164
| +11% | +$11.6M | 0.02% | 711 |
|
|
2020
Q3 | $73M | Buy |
223,147
+56,946
| +34% | +$19.4M | 0.01% | 815 |
|
|
2020
Q2 | $60.5M | Buy |
166,201
+51,391
| +45% | +$13M | 0.01% | 820 |
|
|
2020
Q1 | $24.4M | Buy |
114,810
+8,013
| +8% | +$2.54M | 0.01% | 1134 |
|
|
2019
Q4 | $44M | Buy |
106,797
+3,545
| +3% | +$1.22M | 0.01% | 1035 |
|
|
2019
Q3 | $36.4M | Buy |
103,252
+27,986
| +37% | +$10.4M | 0.01% | 1128 |
|
|
2019
Q2 | $38.1M | Sell |
75,266
-1,450
| -2% | -$1.02M | 0.01% | 1125 |
|
|
2019
Q1 | $76.2M | Buy |
76,716
+26,849
| +54% | +$24.9M | 0.02% | 760 |
|
|
2018
Q4 | $43.3M | Buy |
49,867
+1,751
| +4% | +$1.63M | 0.01% | 973 |
|
|
2018
Q3 | $49.7M | Buy |
48,116
+12,636
| +36% | +$12.4M | 0.01% | 1020 |
|
|
2018
Q2 | $32.6M | Buy |
35,480
+35,215
| +13,289% | +$37.8M | 0.01% | 1232 |
|
|
2018
Q1 | $258K | Buy |
265
+34
| +15% | +$31K | ﹤0.01% | 4278 |
|
|
2017
Q4 | $104K | Buy |
+231
| New | +$85.3K | ﹤0.01% | 4649 |
|
|
2016
Q3 | – | Sell |
-3,605
| Closed | -$2.03M | – | 4529 |
|
|
2016
Q2 | $2.03M | Buy |
3,605
+1,101
| +44% | +$528K | ﹤0.01% | 2798 |
|
|
2016
Q1 | $1.19M | Buy |
2,504
+76
| +3% | +$34.2K | ﹤0.01% | 2991 |
|
|
2015
Q4 | $1.6M | Sell |
2,428
-4,614
| -66% | -$3.49M | ﹤0.01% | 2870 |
|
|
2015
Q3 | $5.53M | Sell |
7,042
-986
| -12% | -$1.2M | ﹤0.01% | 2160 |
|
|
2015
Q2 | $10.6M | Buy |
8,028
+2,262
| +39% | +$2.6M | ﹤0.01% | 1893 |
|
|
2015
Q1 | $5.99M | Sell |
5,766
-244
| -4% | -$161K | ﹤0.01% | 2221 |
|
|
2014
Q4 | $4.02M | Buy |
+6,010
| New | +$3.67M | ﹤0.01% | 2543 |
|
Other funds holding ATRA
RG
VCM
EC
